Vault-13

INOTEK PHARMACEUTICALS CORP RCKT 5.75 08.01.21

NOTE 5.750% 8/0 · US DOMESTIC · CUSIP 45780VAB8

4 institutional holders -5 vs Q4 2019
$13.5mprincipal reported held*
$13.4mreported value*
0 new 0 added 0 reduced 5 sold out net sold ≈ $42.5m

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.

Trends to Q1 2020

Institutional holders

Managers reporting a position, each quarter

0510Q4 19: 9Q1 20: 44Q4 19Q1 20
Numbers
QuarterHolders
Q4 20199
Q1 20204

Biggest buyers

None

Biggest sellers

DeepCurrents Investment Group LLC Sold out -18,100,000-18.1m
CITADEL ADVISORS LLC Sold out -14,750,000-14.8m
Verition Fund Management LLC Sold out -7,300,000-7.3m
CREDIT SUISSE AG/ Sold out -2,500,000-2.5m
Tetragon Partners GP Ltd Sold out -1,000,000-1.0m

Holders, Q1 2020

#ManagerLocationShares Value% of their portfolioChangeShares change
1 WOLVERINE ASSET MANAGEMENT LLC 0.14% of their portfolio CHICAGO, IL 7,500,0007.5m $7.3m $7.3m 0.14% Unchanged
2 DEUTSCHE BANK AG\ 0.00% of their portfolio FRANKFURT AM MAIN, 2M 4,000,0004.0m $4.2m $4.2m 0.00% Unchanged
3 Bruce & Co., Inc. 0.43% of their portfolio CHICAGO, IL 2,000,0002.0m $1.9m $1.9m 0.43% Unchanged
4 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% Unchanged